By Counterforce Health Team in Raxone (idebenone) —

Getting Raxone (Idebenone) Covered by Aetna CVS Health in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Quick Start Guide

Raxone (idebenone) is excluded from Aetna CVS Health's 2024 formularies, requiring a medical exception request for LHON coverage. Fastest path: Submit the Medical Exception/Prior Authorization form with genetic testing results, ophthalmologic documentation, and medical necessity letter. If denied, Illinois residents have 30 days to file an external review with the Illinois Department of Insurance. First step today: Verify your LHON diagnosis with genetic testing for the three common mutations (MT-ND1, MT-ND4, MT-ND6) and gather your ophthalmology records.

Table of Contents

  1. How to Use This Guide
  2. Eligibility Decision Tree
  3. If You're Likely Eligible: Document Checklist
  4. If You're Possibly Eligible: Next Steps
  5. If You're Not Yet Eligible: Alternative Paths
  6. If You're Denied: Illinois Appeals Process
  7. Step-by-Step: Fastest Path to Approval
  8. Common Denial Reasons & Solutions
  9. Cost-Saving Options
  10. FAQ

How to Use This Guide

This guide helps Illinois residents navigate Aetna CVS Health's coverage process for Raxone (idebenone) to treat Leber hereditary optic neuropathy (LHON). Since Raxone is excluded from Aetna's 2024 commercial formularies, you'll need to request a medical exception.

Important: Raxone is not FDA-approved in the United States, though the FDA has accepted it for priority review with a target action date of February 28, 2026. This guide focuses on seeking coverage for off-label use based on European approval and clinical evidence.

Eligibility Decision Tree

Likely Eligible ✅

  • Confirmed LHON diagnosis with genetic testing showing one of the three common mutations (MT-ND1 3460, MT-ND4 11778, MT-ND6 14484)
  • Documented vision loss with characteristic ophthalmologic findings (central scotoma, optic nerve changes)
  • Within treatment window (ideally within 6-12 months of symptom onset, though later stages may still qualify)
  • No contraindications to idebenone treatment

Possibly Eligible ⚠️

  • Clinical suspicion of LHON but genetic testing pending or incomplete
  • Atypical presentation but compatible ophthalmologic findings
  • Family history of LHON but patient asymptomatic
  • Outside typical age range but meeting other criteria

Not Yet Eligible ❌

  • No genetic confirmation and insufficient clinical documentation
  • Alternative diagnosis more likely (inflammatory, nutritional, or toxic optic neuropathy)
  • Contraindications to idebenone treatment
  • Insufficient ophthalmologic documentation

If You're Likely Eligible: Document Checklist

Required Documentation

  • Genetic testing results confirming LHON mutation (targeted testing for three common variants)
  • Ophthalmology records including visual acuity, visual fields, OCT, fundus photography
  • Medical necessity letter from prescribing physician
  • Prior authorization form (Aetna Medical Exception form)
  • Insurance card and member ID
  • Treatment history documenting lack of alternatives

Submission Path

For specialty drugs: Fax to 1-888-267-3277 or submit via Availity portal

If You're Possibly Eligible: Next Steps

Tests to Request

  1. Complete genetic testing for LHON if not already done
  2. Comprehensive eye exam with OCT and visual field testing
  3. Family history documentation (maternal lineage particularly important)
  4. Rule out alternative causes (B12 levels, thyroid function, inflammatory markers)

Timeline to Re-apply

  • Genetic testing results: 2-4 weeks
  • Complete documentation: 1-2 weeks after test results
  • Resubmit exception request: As soon as documentation is complete

If You're Not Yet Eligible: Alternative Paths

Discuss with Your Doctor

  • Low-vision rehabilitation services
  • Supportive care and visual aids
  • Clinical trial participation (check ClinicalTrials.gov)
  • Genetic counseling for family members

Prepare for Future Exception Requests

  • Document progression of vision loss
  • Gather family history of vision problems
  • Consider second opinion from LHON specialist

If You're Denied: Illinois Appeals Process

Illinois residents have strong appeal rights under the Health Carrier External Review Act.

Appeal Levels and Deadlines

Level Timeline How to File Required Forms
Internal Appeal 15 business days for decision Aetna member portal or written request Appeal form from denial letter
Expedited Internal 24-48 hours for urgent cases Call member services Physician attestation of urgency
External Review 30 days from final denial to file Illinois DOI External Review Form DOI form plus supporting documents
Expedited External 24-72 hours for urgent cases Same as above, mark expedited Physician urgency documentation
Critical Illinois Deadline: You have only 30 days from receiving your final appeal denial to request external review—shorter than many states' 4-month window.

Where to Get Help

  • Illinois Department of Insurance: (877) 527-9431
  • Illinois Attorney General Health Care Helpline: (877) 305-5145
  • Counterforce Health: Specialized platform that helps patients and clinicians turn insurance denials into targeted, evidence-backed appeals by analyzing denial letters and drafting point-by-point rebuttals aligned to plan policies.

Step-by-Step: Fastest Path to Approval

Step 1: Confirm LHON Diagnosis (Patient + Clinician)

What to do: Obtain genetic testing for the three common LHON mutations Timeline: 2-4 weeks Source: Prevention Genetics LHON Testing

Step 2: Gather Clinical Documentation (Clinician)

What to do: Compile ophthalmology records, visual function tests, family history Timeline: 1 week Key documents: OCT, visual fields, fundus photos, genetic test results

Step 3: Complete Medical Necessity Letter (Clinician)

What to do: Document LHON diagnosis, lack of FDA-approved alternatives, European approval data Template elements: Diagnosis with ICD-10, genetic confirmation, treatment rationale Timeline: 2-3 days

Step 4: Submit Exception Request (Clinician)

What to do: Complete Aetna Medical Exception form How to submit: Fax to 1-888-267-3277 or via Availity Timeline: Same day

Step 5: Track Decision (Patient)

What to do: Monitor for Aetna's response, typically within 30-45 days Follow-up: Call member services if no response within expected timeframe

Step 6: Appeal if Denied (Patient + Clinician)

What to do: File internal appeal first, then external review if necessary Timeline: Internal appeal within 60 days of denial; external review within 30 days of final denial

Step 7: Escalate to Illinois DOI if Needed (Patient)

What to do: File external review with Illinois Department of Insurance Timeline: Decision within 45 days or 5 days after receiving all documentation

Common Denial Reasons & Solutions

Denial Reason Solution Strategy Required Documentation
"Not FDA-approved" Cite European approval, orphan drug status, lack of alternatives EMA approval documents, medical necessity letter
"Experimental/Investigational" Reference published studies, European clinical use Peer-reviewed literature, treatment guidelines
"Not medically necessary" Document LHON diagnosis, vision loss severity Genetic testing, ophthalmology records, functional assessments
"No prior authorization submitted" Resubmit with complete documentation All required forms and supporting materials
"Insufficient documentation" Provide additional clinical evidence Specialist consultation, additional testing results
Clinician Corner: Medical Necessity Letter Checklist

✅ Problem: LHON diagnosis with genetic confirmation
✅ Prior treatments: Document lack of FDA-approved alternatives
✅ Clinical rationale: European approval, published efficacy data
✅ Guideline citations: EMA approval documents, peer-reviewed studies
✅ Dosing: 300mg three times daily per European labeling
✅ Monitoring: Regular ophthalmologic follow-up plan

Cost-Saving Options

Financial Assistance Programs

  • No current U.S. patient assistance programs available since Raxone lacks FDA approval
  • International pricing: Raxone costs approximately £6,364 per 180×150mg pack in the UK
  • Future programs: Santhera may establish U.S. assistance programs after FDA approval in 2026

Alternative Funding Sources

  • Clinical trials: May provide free medication (search ongoing studies)
  • Rare disease foundations: Contact LHON-specific patient organizations
  • Flexible spending accounts: May cover out-of-pocket costs if prescribed

Frequently Asked Questions

Q: How long does Aetna's prior authorization process take in Illinois? A: Standard decisions typically take 30-45 days. Expedited reviews for urgent cases are completed within 24-72 hours.

Q: What if Raxone is completely excluded from my formulary? A: You can still request a medical exception. Aetna's exclusion lists don't prevent exception requests for medical necessity.

Q: Can I request an expedited appeal in Illinois? A: Yes, if delay would seriously jeopardize your health. Both internal and external expedited appeals are available with physician documentation of urgency.

Q: Does step therapy apply to LHON treatments? A: Since there are no FDA-approved LHON treatments, step therapy requirements typically don't apply. However, insurers may still require documentation of the lack of alternatives.

Q: What happens if my external review is denied? A: External review decisions are binding in Illinois. If denied, you may need to explore other options like clinical trials or international access programs.

Q: How much does genetic testing for LHON cost? A: LHON genetic testing typically costs $300-800 and is often covered by insurance when clinically indicated.

About Counterforce Health: Counterforce Health helps patients, clinicians, and specialty pharmacies get prescription drugs approved by turning insurance denials into targeted, evidence-backed appeals. The platform analyzes denial letters, plan policies, and clinical notes to identify the denial basis and draft point-by-point rebuttals aligned to each plan's specific rules and requirements.

Sources & Further Reading

Disclaimer: This guide is for informational purposes only and does not constitute medical or legal advice. Insurance coverage policies change frequently. Always verify current requirements with your insurance provider and consult with your healthcare provider about treatment options. For personalized assistance with insurance appeals, contact the Illinois Department of Insurance at (877) 527-9431 or the Illinois Attorney General's Health Care Helpline at (877) 305-5145.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.